ArticleCancer management and research2025
Circ_CIT Promotes Nasopharyngeal Carcinoma Progression and Macrophage M2 Polarization Through miR-409-3p/ZEB1 Axis.
Article in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Circular RNAs (circRNAs) play a crucial role in the progression of various cancers, including nasopharyngeal carcinoma (NPC). However, the mechanism of circRNA in the progression of NPC remains to be elucidated. Patients and Methods: The expression levels of circ_CIT, microRNA-409-3p and ZEB1 in NPC tissues were detected by Real-time quantitative PCR (qRT-PCR). Nuclear separation and fluorescence in situ hybridization (FISH) assays were used to determine the localization of circ_CIT. Dual luciferase reporter was performed to confirm the binding of circ_CIT with micro (miR)-409-3p. Cellular behaviors were determined using Cell Counting Kit-8 (CCK-8), colony formation, wound healing, transwell and macrophage chemotaxis assays. Enzyme Linked Immunosorbent Assay (ELISA) and immunofluorescence Assays was used to evaluated macrophage markers. Results: We identified that circ_CIT was mainly located in the cytoplasm. Circ_CIT expression was increased in NPC tissues and cell lines. Knockdown of circ_CIT inhibited cell proliferation, invasion and migration. Circ_CIT-mediated NPC tumorigenesis by sponging miR-409-3p and promoting ZEB1 expression. The inhibitors of miR-409-3p could reverse the effects of circ_CIT knockdown on NPC cells. The expression of circ_CIT and ZEB1 was found to be positively correlated with NPC tumor stage. Downregulation of expression of circ_CIT could promote macrophage M2 polarization through NPC cells. Overexpression of ZEB1 could reverse the inhibitory effect of circ_CIT knockdown on the polarization of macrophages to M2 phenotype. Conclusion: Highly expressed circ_CIT adsorbs miR-409-3p to upregulate ZEB1 expression, thereby promoting the proliferation and metastatic ability of NPC cells and activating macrophage M2 polarization. Therefore, circ_CIT may be a potential therapeutic target for NPC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.